Cargando…

FluBlok, a recombinant hemagglutinin influenza vaccine

Abstract FluBlok, a recombinant trivalent hemagglutinin (HA) vaccine produced in insect cell culture using the baculovirus expression system, provides an attractive alternative to the current egg‐based trivalent inactivated influenza vaccine (TIV) manufacturing process. FluBlok contains three times...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cox, Manon M.J., Patriarca, Peter A., Treanor, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2008
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634115/ https://www.ncbi.nlm.nih.gov/pubmed/19453397 http://dx.doi.org/10.1111/j.1750-2659.2008.00053.x

Ejemplares similares

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans
por: Stadlbauer, Daniel, et al.
Publicado: (2017)

Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine
por: Wang, Keyang, et al.
Publicado: (2006)

The life of Aleksandr Blok
por: Pyman, Avril
Publicado: (1979)

The life of Aleksandr Blok /
por: Pyman, Avril
Publicado: (1979)

Alexander Blok as man and poet /
por: Chukovsky, Kornei, 1882-1969
Publicado: (1982)

Aleksandr Blok: the journey to Italy : with English translations of the poems and prose sketches on Italy
por: Vogel, Lucy E.

Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability
por: Feshchenko, Elena, et al.
Publicado: (2012)

Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice
por: Wang, Jiong, et al.
Publicado: (2018)

Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins
por: Tussey, Lynda, et al.
Publicado: (2016)

Recombinant protein vaccines produced in insect cells
por: Cox, Manon M.J.
Publicado: (2012)

Strategies Targeting Hemagglutinin as a Universal Influenza Vaccine
por: Bullard, Brianna L., et al.
Publicado: (2021)

Univ-flu: A structure-based model of influenza A virus hemagglutinin for universal antigenic prediction
por: Qiu, Jingxuan, et al.
Publicado: (2022)

Vaccination against Influenza with Recombinant Hemagglutinin Expressed by Schizochytrium sp. Confers Protective Immunity
por: Bayne, Anne-Cécile V., et al.
Publicado: (2013)

Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions
por: Mittal, Nidhi, et al.
Publicado: (2021)

The Development and Study of Recombinant Immunoglobulin A to Hemagglutinins of the Influenza Virus
por: Aliev, T. K., et al.
Publicado: (2018)

Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans
por: Nachbagauer, Raffael, et al.
Publicado: (2016)

Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adults
por: Oshansky, Christine M., et al.
Publicado: (2021)

Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy
por: Gallagher, John R., et al.
Publicado: (2018)

Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
por: Steel, John, et al.
Publicado: (2010)

Influenza hemagglutinin membrane anchor
por: Benton, Donald J., et al.
Publicado: (2018)

Snijders Blok–Campeau Syndrome: Description of 20 Additional Individuals with Variants in CHD3 and Literature Review
por: Pascual, Patricia, et al.
Publicado: (2023)

Simple and rapid plaque assay for recombinant baculoviruses expressing influenza hemagglutinin
por: Basak, Swarnendu, et al.
Publicado: (2021)

Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins
por: Blanchfield, Kristy, et al.
Publicado: (2014)

Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components
por: Hernandez-Davies, Jenny E., et al.
Publicado: (2021)

Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants
por: Hernandez-Davies, Jenny E., et al.
Publicado: (2022)

Structural Biology of Influenza Hemagglutinin: An Amaranthine Adventure
por: Wu, Nicholas C., et al.
Publicado: (2020)

Squalene-Based Influenza Vaccine Adjuvants and Their Impact on the Hemagglutinin-Specific B Cell Response
por: Nguyen-Contant, Phuong, et al.
Publicado: (2021)

Comparison of Serum Hemagglutinin and Neuraminidase Inhibition Antibodies After 2010–2011 Trivalent Inactivated Influenza Vaccination in Healthcare Personnel
por: Laguio-Vila, Maryrose R., et al.
Publicado: (2014)

Development of live cultural pandemic influenza vaccine Vector-Flu
por: Nechaeva, Elena A, et al.
Publicado: (2011)

Vaccine effect of recombinant single-chain hemagglutinin protein as an antigen
por: Kawai, Atsushi, et al.
Publicado: (2020)

Enhanced Potency and Durability of Antibody Response to Seasonal Trivalent Inactivated Influenza Vaccine (TIV) Combined with a Novel Water-in-Oil Adjuvant System at Reduced Hemagglutinin (HA) Doses
por: Gorse, Geoffrey J, et al.
Publicado: (2017)

Cinco poetas rusos ; A propósito de Blok, Sologu, Gumiliov, Ajmátova, Mandelstam y su obra

Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins
por: Gamblin, Steven J., et al.
Publicado: (2010)

Erratum: Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components
Publicado: (2021)

Innovations in the Insect Cell Expression System for Industrial Recombinant Vaccine Antigen Production
por: Cox, Manon M. J.
Publicado: (2021)

In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen
por: Wohlbold, Teddy John, et al.
Publicado: (2014)

Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines
por: Jiang, Shibo, et al.
Publicado: (2010)

Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D
por: Hartshorn, Kevan L, et al.
Publicado: (2008)

A second cohort of CHD3 patients expands the molecular mechanisms known to cause Snijders Blok-Campeau syndrome
por: Drivas, Theodore G., et al.
Publicado: (2020)

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
por: Kumari, Sushmita, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_49gcrg7g6jh6s49ith4vmbkbij